Got questions about navigating life with diabetes? Ask D'Mine! Our time period advice column, that is, hosted away veteran type 1 and diabetes author Wil Dubois. This week, Wil is talking prediabetes and that delicate topic of "preventing" type 2 diabetes from subsiding in for the long run.

{Got your own questions? Email us at AskDMine@diabetesmine.com}

Peter, prediabetic from Maine, writes: I cause an interest in the use of Actos and saxagliptan for treating prediabetes. Can you help? I own scan your article where you say that dispatch judge use of Actos for treating prediabetes is common. Can you measure this? Cause you deliver the same information connected saxagliptan? Too, is this a repair-driven phenomenon, or involuntary by Takeda and AstraZeneca, the drugs' makers?

Wil@Ask D'Mine answers: Wow. Nothing on the Internet ever dies, does it? There's no date on the article you referred to, and IT's been many, more years since I've written for those folks — although I exercise see that I apparently answered a call into question on their website a mere seven days ago. Either I'm answering diabetes questions in my slumber (always a possibility) operating theatre they're recycling old corporate and making it look unused. Well, it's theirs to recycle, but I find that a hair on the sleazy side.

That said, I re-read the short-dated small-arm that you'Ra request about, and it's not gravely out of date, even though I do flavour it should be in its serious by now.

Unsatisfactory Judge Use

But on to your questions: Introductory to off label use. Here's the deal: About drugs can actually do more one matter, but it takes frreakin' everlastingly to pay off a dose approved for a single use, much less for a portfolio of uses. Meanwhile, as far as profitableness goes, drugs have a telescoped ledge life before the patent protection goes away and the Colonel's secret recipe ends up on the Internet. All of this means there's microscopic motivation for the makers of drugs to pursue extra indications from the FDA, even if the makers have good reason to suspect a given Master of Education could be used for other health conditions to healthful impression.

Record the doctors. They know this, too. So many docs maintain a close eye on clinical explore in their given W. C. Fields, and if they read approximately a med being used to good effectuate for something information technology's non approved for, they can choose to prescribe information technology off label. Off pronounce simply means the do drugs is being precondition for a condition not listed in its approval—its "labeling." To be assoil, docs sack prescribe whatever they deficiency. Fountainhead… they used to be able to.

Enter the health insurance companies. Always look for shipway to deny reportage of things, and thus preserve their profits to the maximum point viable, the latest trick of the insurance companies is to refuse insurance coverage for off label drugs, often under the pretence of patient safety, saying something like, we care too so much about you to let that nasty ol' doctor prescribe a med for a use that the FDA hasn't authorized… Yea. Right. Oh, as a side note, it used to exist that any medico could successfully get an bump off-label Rx covered, then a few years ago, only specialists had any luck, and now even narrowly focused professionals are having a hard prison term.

Entirely of this said, how common was off label wont, back when information technology was easy through with? Explore from 2006 showed that fully 21% of altogether prescriptions written were off label. Just as to your request that I measure how common prescribing Actos for prediabetes was, sorry, I can't find whatever information specifically thereon, operating theatre level connected how many diabetes meds as a year were Rx'd off mark up. Back when I wrote that original while I saw it pass fairly usually, but as famous above, the world has changed a lot since then. As a matter of fact, I'm confident that spell the percentage of all hit recording label prescribing is dramatically lower now ascribable lack of coverage—bearing in mind that most drugs are priced thusly high that if your insurance isn't helping away, it's doubtful you can afford to disburse of pocket for an off pronounce treatment. I funny that off judge Actos prescribing is even more low. Why is that?

Portion out on Pinterest

Symptomless, Actos has been on a wild ride since I last wrote about it.

Which Medications Work for Prediabetes?

After a short stint as about of the popular drugs in the world, the class of drugs that Actos belongs to, thiazolidinediones (TZDs), got a black middle when it came to long-wooled-term side personal effects, quickly tanked in popularity, and ne'er healed. But that aside for the time being, did they really help prediabetes? Yep. As a topic of fact there were a number of studies that showed drugs in the TZD class could delay the onset of type 2 diabetes for people who had prediabetes. Of of course, nigh of those studies were undertaken before the fall, when TZDs were firstborn-line drugs for diabetes. Currently, they are quasi-toxic from a liability perspective.

Now, atomic number 3 to saxagliptan, that's a whole 'nother hole. Actos was first base approved back in 1999, and saxagliptan a full decade subsequent, when information technology was calm owned by Bristol-Myers Squibb. The med doesn't look to have been studied atomic number 3 widely as TZDs were for prediabetes. I found evidence of two clinical trials that were recruiting in the then, but couldn't obtain any results. Maybe they're still in the whole kit. Maybe I just missed them. Or maybe they were buried. In any case, in that location doesn't seem to be as much grounds for saxagliptan beingness effective against prediabetes as in that respect was for the TZDs. And like TZDs, saxagliptan isn't without its fallout risks, the FDA new adding a warning to its label some heart failure risk.

The Danger-Benefit Equation

Diabetes will mess you upwardly. Well, it has the prospective to in any case, so if diabetes potty exist delayed—surgery avoided altogether—I think we can entirely concord that this would make up a sainted thing. Unless the med you go for delay or keep off diabetes messes you up even worse. In which case, what consume you gained?

And that's the crux of the problem with taking powerful meds for a developing experimental condition that itself is but a kitten—granted, one that will grow rising someday to be a tiger. But caution is indicated here. These drugs have the potential for serious incline effects. Noneffervescent, that said, given the body of tell apart, I recall you mightiness be able to make a case for taking Actos, goodby as you don't as yet have any other vessel risk factors (including a strong family history). And if your doc found some data on saxagliptan that I uncomprehensible, the same holds true. But taking two meds with dark clouds in their silver linings?

No. That I buns't look. To me, that places waaaaaaaay to much risk on the put on the line side of the take chances-benefit seesaw.

And there's one and only other matter to think about here. Type 2 diabetes, like diamonds, is forever. If and once you receive IT, information technology doesn't go away. It's also progressive, which means that even in the face of best efforts, it gets worse. Worthless, I know I'm depressing you, but there's a reason out. We know that diabetes meds generally become less efficient over prison term. Some people believe that this is simply attributable the ascending military capability of the diabetes over time. Others, including ME, believe that the body adapts to nigh medicines concluded sentence, fashioning them less and less effective. This is called medication tolerance. If I blow my shot with ii diabetes meds in the first inning of the game, what volition I have left in the twenty-five percent inning? In the ninth?

Less Unsafe Alternatives

Now, for what IT's deserving, there's another intimately-documented way to retard type 2 diabetes. Information technology's not unsafe at all, merely for many people it seems to cost a hard pill to live with. On the loose some weight. Want to sheared your diabetes chance in half? Loose between five and ten percent of your body weight. IT's that simple (even though acquiring there can be ambitious).

Off Label Drivers

And finally, to your question of WHO drove the dying unsatisfactory label delirium: The docs or the drug companies? Cured, low gear off, let's be clear that it's illegal for pharma companies to market their products for cancelled label use up. Unfortunately their sales teams are allowed to allow copies of medical examination journal articles or studies of off label use of their products. Isn't that marketing? Apparently non, but the ice sure is thin.

And thither's no doubt that many pharma companies have abused the privilege in the medieval to drive sales, and some apparently still bear on to do so. But let's be clear: The drug companionship doesn't write the hand. The vaulting horse Michigan with your doctor. If your docs writes prescriptions because the pretty blonde pharma rep gave him a re-create of a diary article, alternatively of carefully perusal the science independently, so my prescription for you is to amaze a new doc.

This is not a medical advice column. We are PWDs freely and openly sharing the wisdom of our assembled experiences — our been-there-finished-that knowledge from the trenches. Bottom Line: You stillness need the guidance and care of a licensed medical exam professional.